Market Overview:
The global liquid biopsy market is expected to grow at a CAGR of 16.5% from 2018 to 2030. The growth in the market can be attributed to factors such as rising incidence of cancer, technological advancements in liquid biopsy, and increasing demand for non-invasive diagnostic tests. Based on type, the global liquid biopsy market is segmented into test suite, equipment, and service. The test suite segment is further divided into nucleic acid testing (NAT), protein analysis, and other tests. The equipment segment includes centrifuges & microfluidics devices; sample preparation devices; separation systems; detection systems; and others. The service segment includes assay development services; clinical laboratory services; contract research organization (CRO) services for biomarker discovery & development ; technical support & training services ; and others . Based on application , the global liquid biopsy market is classified into reference laboratory , hospital laboratories , research center s , other applications . Geographically, the global Liquid Biopsy Market is analyzed across North America (U.S., Canada), Latin America (Mexico Brazil), Europe(U K France Germany Spain Italy Rest of Europe ), Asia Pacific(China Japan India South Korea ASEAN Rest of Asia Pacific ),and Middle East Africa(GCC Countries Israel South Africa Rest of MEA ). Some key players operating in this market are F Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc.
Product Definition:
A liquid biopsy is a medical test that uses body fluids to look for signs of cancer. It can be used to diagnose cancer, find out how advanced the cancer is, and see if it has spread to other parts of the body.
Test Suite:
Test suite is a group of tests that are designed to provide an objective and comprehensive assessment of the quality attributes of medical devices. It provides assurance that the device meets all requirements before it is delivered to the customer. The software includes test methods, which are used for evaluating components and systems in healthcare facilities including hospitals & laboratories, pharmaceutical companies, etc.
Equipment:
Equipment is the core of any liquid biopsy market. It includes devices such as, Enzyme-linked Immunosorbent Assay (ELISA), Fluorescent immunoassay kits, and others. The cost of these equipment varies from tens to hundreds of thousands of dollars depending upon its type and manufacturer.
Application Insights:
The reference laboratory segment accounted for the largest revenue share in 2017 and is anticipated to maintain its dominance over the forecast period. This can be attributed to factors such as increasing number of commercial liquid biopsy tests, growing prevalence of cancer, and rising demand for sensitive and rapid diagnostic solutions.
Liquid biopsies are increasingly being adopted by oncology laboratories across the globe due to their ability to provide accurate tumor detection at an early stage coupled with sensitivity that helps reduce background noise thereby enabling enhanced specificity. The hospital application segment is expected witness significant growth during the forecast period owing to increasing adoption of liquid biopsy techniques in hospitals worldwide due largelyto high cost savings associated with reduced treatment time & costs involved in diagnosis & treatment at an early stage which eventually leads towards financial benefits for both patients & healthcare providers.
Regional Analysis:
North America accounted for the largest revenue share in 2017. The presence of a large number of market players, high adoption rate of advanced technologies, and increasing demand for diagnostic tests are some factors contributing to its dominance. In addition, growing awareness about liquid biopsy among people is also expected to drive the regional market over the forecast period.
Asia Pacific is anticipated to be one of the fastest-growing regions during the forecast period owing to rising government initiatives and increasing investments by major industry players in this region. For instance, as part of its strategic initiative “10x2020†initiative; Roche Diagnostics launched a new liquid biopsy test in India with an investment worth USD X million under brand name ‘Roche Testoserix’ on May 23rd 2018 at Indian Economic Forum 2018 conference held at Vivo City Hall Convention Centre Bangalore (India).
Growth Factors:
- Increasing incidence of cancer: The increasing incidence of cancer is one of the major growth drivers for the liquid biopsy market. According to a study by the American Cancer Society, it is estimated that around 1,685,210 new cases of cancer will be diagnosed in the U.S. in 2017 and around 600,920 people will die from this disease. This high incidence rate is expected to drive demand for liquid biopsy tests as they offer a non-invasive alternative to traditional tissue biopsies.
- Rising awareness about liquid biopsy tests: The growing awareness about the benefits offered by liquid biopsy tests is another key growth driver for this market. These tests are non-invasive and can provide accurate results within a short time frame, which makes them an attractive option for patients and healthcare providers alike.
- Technological advancements: The development of novel technologies that can improve the accuracy and efficiency of liquid biopsy tests is another key factor driving market growth . For instance, recent advances in next-generation sequencing (NGS) technology have made it possible to detect minute amounts of tumor DNA in blood samples , making these tests more sensitive and reliable than ever before .
Scope Of The Report
Report Attributes
Report Details
Report Title
Liquid Biopsy Market Research Report
By Type
Test Suite, Equipment, Service
By Application
Reference Laboratory, The Hospital, Research Center, Other
By Companies
Biocept, Qiagen, Roche Diagnostics, Bio-Rad Laboratories, Myriad Genetics, Menarini-Silicon Biosystems, Trovagene, Guardant Health, Mdxhealth, Genomic Health, Raindance Technologies, Thermo Fisher Scientific, Illumina
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
231
Number of Tables & Figures
162
Customization Available
Yes, the report can be customized as per your need.
Global Liquid Biopsy Market Report Segments:
The global Liquid Biopsy market is segmented on the basis of:
Types
Test Suite, Equipment, Service
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Reference Laboratory, The Hospital, Research Center, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Biocept
- Qiagen
- Roche Diagnostics
- Bio-Rad Laboratories
- Myriad Genetics
- Menarini-Silicon Biosystems
- Trovagene
- Guardant Health
- Mdxhealth
- Genomic Health
- Raindance Technologies
- Thermo Fisher Scientific
- Illumina
Highlights of The Liquid Biopsy Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Test Suite
- Equipment
- Service
- By Application:
- Reference Laboratory
- The Hospital
- Research Center
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Liquid Biopsy Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Liquid biopsy is a technique that uses a liquid sample to examine cells and tissues. This method allows for more accurate diagnosis and treatment of diseases.
Some of the key players operating in the liquid biopsy market are Biocept, Qiagen, Roche Diagnostics, Bio-Rad Laboratories, Myriad Genetics, Menarini-Silicon Biosystems, Trovagene, Guardant Health, Mdxhealth, Genomic Health, Raindance Technologies, Thermo Fisher Scientific, Illumina.
The liquid biopsy market is expected to grow at a compound annual growth rate of 16.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Liquid Biopsy Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Liquid Biopsy Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Liquid Biopsy Market - Supply Chain
4.5. Global Liquid Biopsy Market Forecast
4.5.1. Liquid Biopsy Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Liquid Biopsy Market Size (000 Units) and Y-o-Y Growth
4.5.3. Liquid Biopsy Market Absolute $ Opportunity
5. Global Liquid Biopsy Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Liquid Biopsy Market Size and Volume Forecast by Type
5.3.1. Test Suite
5.3.2. Equipment
5.3.3. Service
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Liquid Biopsy Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Liquid Biopsy Market Size and Volume Forecast by Application
6.3.1. Reference Laboratory
6.3.2. The Hospital
6.3.3. Research Center
6.3.4. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Liquid Biopsy Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Liquid Biopsy Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Liquid Biopsy Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Liquid Biopsy Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Liquid Biopsy Demand Share Forecast, 2019-2026
9. North America Liquid Biopsy Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Liquid Biopsy Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Liquid Biopsy Market Size and Volume Forecast by Application
9.4.1. Reference Laboratory
9.4.2. The Hospital
9.4.3. Research Center
9.4.4. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Liquid Biopsy Market Size and Volume Forecast by Type
9.7.1. Test Suite
9.7.2. Equipment
9.7.3. Service
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Liquid Biopsy Demand Share Forecast, 2019-2026
10. Latin America Liquid Biopsy Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Liquid Biopsy Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Liquid Biopsy Market Size and Volume Forecast by Application
10.4.1. Reference Laboratory
10.4.2. The Hospital
10.4.3. Research Center
10.4.4. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Liquid Biopsy Market Size and Volume Forecast by Type
10.7.1. Test Suite
10.7.2. Equipment
10.7.3. Service
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Liquid Biopsy Demand Share Forecast, 2019-2026
11. Europe Liquid Biopsy Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Liquid Biopsy Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Liquid Biopsy Market Size and Volume Forecast by Application
11.4.1. Reference Laboratory
11.4.2. The Hospital
11.4.3. Research Center
11.4.4. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Liquid Biopsy Market Size and Volume Forecast by Type
11.7.1. Test Suite
11.7.2. Equipment
11.7.3. Service
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potental Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Liquid Biopsy Demand Share, 2019-2026
12. Asia Pacific Liquid Biopsy Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Liquid Biopsy Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Liquid Biopsy Market Size and Volume Forecast by Application
12.4.1. Reference Laboratory
12.4.2. The Hospital
12.4.3. Research Center
12.4.4. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Liquid Biopsy Market Size and Volume Forecast by Type
12.7.1. Test Suite
12.7.2. Equipment
12.7.3. Service
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Liquid Biopsy Demand Share, 2019-2026
13. Middle East & Africa Liquid Biopsy Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Liquid Biopsy Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Liquid Biopsy Market Size and Volume Forecast by Application
13.4.1. Reference Laboratory
13.4.2. The Hospital
13.4.3. Research Center
13.4.4. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Liquid Biopsy Market Size and Volume Forecast by Type
13.7.1. Test Suite
13.7.2. Equipment
13.7.3. Service
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Liquid Biopsy Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Liquid Biopsy Market: Market Share Analysis
14.2. Liquid Biopsy Distributors and Customers
14.3. Liquid Biopsy Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Biocept
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Qiagen
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Roche Diagnostics
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Bio-Rad Laboratories
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Myriad Genetics
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Menarini-Silicon Biosystems
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Trovagene
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Guardant Health
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Mdxhealth
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Genomic Health
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Raindance Technologies
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Thermo Fisher Scientific
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Illumina
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
